- IN₹1.03tn
- IN₹1.06tn
- IN₹142.78bn
Mankind Pharma's quarterly profit jumps 39% on strong chronic drug demand
India's Mankind Pharma gains on higher quarterly profit
Brief: Mankind Pharma Says To Buy 70% Majority Stake In Armed Cell Therapeutics Through Unit
Kotak upgrades India's Mankind Pharma to 'buy' on signs of business recovery
Brief: Mankind Pharma Accords Approval For Voluntary Liquidation Of Unit Bharat Serums And Vaccines
India's Mankind Pharma posts quarterly profit growth on chronic drug demand
Brief: Mankind Pharma June-Quarter Consol Net Profit 5.68 Billion Rupees
Brief: Mankind Pharma Buys Remaining 10% Stake In Upakarma
India's top condom maker may hike prices on war-linked oil surge
India's Mankind Pharma climbs on strong Q4 profit
Indian drugmaker Mankind posts strong quarterly profit on demand for chronic therapies
Brief: Mankind Pharma March-Quarter Consol Profit From Continuing Operations 5.59 Billion Rupees
Indian pharma shares extend losses on US tariffs; brokerages see limited impact
Morgan Stanley initiates coverage on India's Torrent Pharma, Mankind Pharma
Novo Nordisk patent expiry opens door to cheaper weight-loss drugs in India
India's Mankind Pharma rises on buying new drug rights
Brief: Mankind Pharma Buys Rivotril Brand From Roche For India
Brief: Mankind Pharma Says Tax Penalty Of 10.2 Million Rupees Dropped
Brief: Mankind Pharma Says Tax Penalty Of 4.6 Million Rupees Dropped